MASTERINVEST Kapitalanlage GmbH Makes New Investment in The Ensign Group, Inc. $ENSG

MASTERINVEST Kapitalanlage GmbH purchased a new position in shares of The Ensign Group, Inc. (NASDAQ:ENSGFree Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 6,600 shares of the company’s stock, valued at approximately $1,058,000.

Other hedge funds also recently modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after purchasing an additional 230 shares during the period. EverSource Wealth Advisors LLC grew its holdings in The Ensign Group by 65.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi increased its position in shares of The Ensign Group by 480,216.7% during the second quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after buying an additional 57,626 shares during the period. Finally, Brown Advisory Inc. increased its position in shares of The Ensign Group by 26.1% during the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after buying an additional 421 shares during the period. Institutional investors own 96.12% of the company’s stock.

The Ensign Group Stock Performance

NASDAQ:ENSG opened at $172.98 on Friday. The firm has a market cap of $10.08 billion, a PE ratio of 27.11, a price-to-earnings-growth ratio of 1.67 and a beta of 0.68. The Ensign Group, Inc. has a fifty-two week low of $141.58 and a fifty-two week high of $218.00. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The business has a 50 day moving average price of $173.40 and a 200-day moving average price of $184.22.

The Ensign Group (NASDAQ:ENSGGet Free Report) last posted its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The Ensign Group’s quarterly revenue was up 16.7% on a year-over-year basis. During the same period last year, the firm earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities research analysts predict that The Ensign Group, Inc. will post 6.93 earnings per share for the current year.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were given a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.26 annualized dividend and a yield of 0.2%. The Ensign Group’s dividend payout ratio (DPR) is currently 4.08%.

Insiders Place Their Bets

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the sale, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the transaction, the director owned 9,503 shares in the company, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company’s stock.

Wall Street Analysts Forecast Growth

ENSG has been the topic of a number of analyst reports. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Wall Street Zen lowered shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Truist Financial upped their price target on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a research report on Tuesday, July 28th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $216.25.

Read Our Latest Stock Report on ENSG

About The Ensign Group

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Further Reading

Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSGFree Report).

Institutional Ownership by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.